(NASDAQ: CRBU) Caribou Biosciences's forecast annual revenue growth rate of -26.72% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.04%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.92%.
Caribou Biosciences's revenue in 2024 is $34,477,000.On average, 3 Wall Street analysts forecast CRBU's revenue for 2024 to be $1,216,175,070, with the lowest CRBU revenue forecast at $903,145,010, and the highest CRBU revenue forecast at $1,481,157,816. On average, 2 Wall Street analysts forecast CRBU's revenue for 2025 to be $1,210,665,886, with the lowest CRBU revenue forecast at $903,145,010, and the highest CRBU revenue forecast at $1,518,186,762.
In 2026, CRBU is forecast to generate $1,229,631,931 in revenue, with the lowest revenue forecast at $903,145,010 and the highest revenue forecast at $1,556,118,852.